Johnson & Johnson asks FDA for emergency use authorization for 1-shot COVID vaccine
New Jersey-based pharmaceutical company Johnson & Johnson announced that it has submitted an application to the Food and Drug Administration asking for emergency use authorization for its one-shot Janssen COVID-19 vaccine candidate.
Share:
